Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Increlex and NutropinAq in children with IGF-1 deficiency
NCT00572156Phase 2Terminated
- Sponsor
- Ipsen
- Start
- Dec 2007
- Primary completion
- Apr 2010
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of mecasermin in insulin-like growth factor 1 deficiency (4 arms), sponsored by Ipsen. Primary endpoint: Height Velocity at 1 year. Started Dec 2007; status: terminated.
02
Drugs
mecasermin
03
Conditions
insulin-like growth factor 1 deficiency
Beyond the preview
Go deeper on NCT00572156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00572156.